{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:48:15Z","timestamp":1765878495370,"version":"3.48.0"},"reference-count":48,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,10,4]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The presence of cognitive dysfunction notably affects the quality of life in individuals diagnosed with Parkinson\u2019s disease (PD) and is often recognised as a non-motor symptom. Comprehensive studies have shown the possible advantages of hyperbaric oxygen therapy (HBOT) in alleviating cognitive deficits in these individuals. This systematic review aims to investigate the practicality of incorporating HBOT within a more extensive therapeutic framework for PD, with a specific focus on cognitive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A comprehensive literature review will be conducted utilising various databases such as PubMed and Cochrane Library and so on. The duration of the search will encompass the entire timeline from the initiation of each database up to 1 April 2024. This investigation seeks to uncover randomised controlled trials that explore the efficacy and safety of HBOT in patients with PD who are facing cognitive impairments. The authors' autonomous screening and extraction of data will facilitate the attainment of impartial results. The assessment of possible biases will be conducted using the Cochrane risk-of-bias tool, while statistical analyses will be executed with RevMan V.5.3 and Stata V.15.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>As this review synthesises and evaluates previously conducted studies, the requirement for ethical approval is not applicable. The findings from this review will be shared via academic publications, comprehensive reports and presentations at pertinent conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42024504763<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-087164","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T01:05:59Z","timestamp":1732151159000},"page":"e087164","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of hyperbaric oxygen therapy for Parkinson\u2019s disease with cognitive dysfunction: protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-0214","authenticated-orcid":false,"given":"Weiqiang","family":"Tan","sequence":"first","affiliation":[{"name":"Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoquan","family":"Pan","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxi","family":"Xie","sequence":"additional","affiliation":[{"name":"Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"2025121601434154000_14.11.e087164.1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27902"},{"key":"2025121601434154000_14.11.e087164.2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","article-title":"Mild cognitive impairment in Parkinson\u2019s disease: the Parkinson\u2019s disease cognitive study (PACOS)","volume":"265","author":"Monastero","year":"2018","journal-title":"J Neurol"},{"key":"2025121601434154000_14.11.e087164.3","doi-asserted-by":"crossref","first-page":"120077","DOI":"10.1016\/j.jns.2021.120077","article-title":"Frequency of dementia in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"432","author":"Severiano E Sousa","year":"2022","journal-title":"J Neurol Sci"},{"key":"2025121601434154000_14.11.e087164.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.034"},{"key":"2025121601434154000_14.11.e087164.5","doi-asserted-by":"publisher","DOI":"10.1177\/1533317516653823"},{"key":"2025121601434154000_14.11.e087164.6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jamaneurol.2017.1474","article-title":"Impaired Cognition and the Risk of Parkinson Disease: Trouble in Mind","volume":"74","author":"Brown","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025121601434154000_14.11.e087164.7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"2025121601434154000_14.11.e087164.8","doi-asserted-by":"crossref","DOI":"10.3390\/bs11050074","article-title":"Cognitive Impairment in Parkinson\u2019s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"2025121601434154000_14.11.e087164.9","first-page":"762","article-title":"The diagnostic criteria and treatment guideline for Parkinson\u2019s disease dementia (second version)","volume":"54","year":"2021","journal-title":"Chin J Neurol"},{"key":"2025121601434154000_14.11.e087164.10","doi-asserted-by":"publisher","DOI":"10.1177\/0891988716654985"},{"key":"2025121601434154000_14.11.e087164.11","first-page":"e2045","article-title":"Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study","volume":"91","author":"B\u00e4ckstr\u00f6m","year":"2018","journal-title":"Neurology (ECronicon)"},{"key":"2025121601434154000_14.11.e087164.12","doi-asserted-by":"crossref","first-page":"117177","DOI":"10.1016\/j.jns.2020.117177","article-title":"Cognitive impairment in Parkinson\u2019s disease: A clinical and pathophysiological overview","volume":"419","author":"Brand\u00e3o","year":"2020","journal-title":"J Neurol Sci"},{"key":"2025121601434154000_14.11.e087164.13","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59101756","article-title":"Cognitive Impairment in Parkinson\u2019s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches","volume":"59","author":"Degirmenci","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"2025121601434154000_14.11.e087164.14","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26352"},{"key":"2025121601434154000_14.11.e087164.15","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad205","article-title":"Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis","volume":"52","author":"Ahuja","year":"2023","journal-title":"Age Ageing"},{"key":"2025121601434154000_14.11.e087164.16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.brs.2018.07.046","article-title":"Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study","volume":"11","author":"Manenti","year":"2018","journal-title":"Brain Stimul"},{"key":"2025121601434154000_14.11.e087164.17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.brs.2015.07.043","article-title":"Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients With Mild Cognitive Impairment Receiving Cognitive Training","volume":"8","author":"Biundo","year":"2015","journal-title":"Brain Stimul"},{"key":"2025121601434154000_14.11.e087164.18","article-title":"Cognitive Training and Transcranial Direct Current Stimulation for Mild Cognitive Impairment in Parkinson\u2019s Disease: A Randomized Controlled Trial","volume":"2018","author":"Lawrence","year":"2018","journal-title":"Parkinsons Dis"},{"key":"2025121601434154000_14.11.e087164.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-012-3255-9"},{"key":"2025121601434154000_14.11.e087164.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146506"},{"key":"2025121601434154000_14.11.e087164.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2018.01.002"},{"key":"2025121601434154000_14.11.e087164.22","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16050880","article-title":"Eight Weeks of Aerobic Interval Training Improves Psychomotor Function in Patients with Parkinson\u2019s Disease-Randomized Controlled Trial","volume":"16","author":"Marusiak","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025121601434154000_14.11.e087164.23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10072-014-1666-z","article-title":"Neurofunctional correlates of attention rehabilitation in Parkinson\u2019s disease: an explorative study","volume":"35","author":"Cerasa","year":"2014","journal-title":"Neurol Sci"},{"key":"2025121601434154000_14.11.e087164.24","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23688"},{"key":"2025121601434154000_14.11.e087164.25","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091247","article-title":"Molecular and Therapeutic Aspects of Hyperbaric Oxygen Therapy in Neurological Conditions","volume":"10","author":"Fischer","year":"2020","journal-title":"Biomolecules"},{"key":"2025121601434154000_14.11.e087164.26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11357-022-00707-z","article-title":"The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases","volume":"45","author":"Mensah-Kane","year":"2023","journal-title":"Geroscience"},{"key":"2025121601434154000_14.11.e087164.27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11065-021-09500-9","article-title":"Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review","volume":"32","author":"Marcinkowska","year":"2022","journal-title":"Neuropsychol Rev"},{"key":"2025121601434154000_14.11.e087164.28","doi-asserted-by":"crossref","DOI":"10.1002\/trc2.12030","article-title":"Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"6","author":"Chen","year":"2020","journal-title":"A&D Transl Res & Clin Interv"},{"key":"2025121601434154000_14.11.e087164.29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3233\/JAD-210157","article-title":"A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer\u2019s Disease","volume":"81","author":"Somaa","year":"2021","journal-title":"JAD"},{"key":"2025121601434154000_14.11.e087164.30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fnagi.2019.00086","article-title":"Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia","volume":"11","author":"You","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"2025121601434154000_14.11.e087164.31","doi-asserted-by":"crossref","DOI":"10.3390\/biom12050661","article-title":"Hyperbaric Oxygen Therapy Improves Parkinson\u2019s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1\/PGC-1\u03b1 Pathway","volume":"12","author":"Hsu","year":"2022","journal-title":"Biomolecules"},{"key":"2025121601434154000_14.11.e087164.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025121601434154000_14.11.e087164.33","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21844"},{"key":"2025121601434154000_14.11.e087164.34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"2025121601434154000_14.11.e087164.35","first-page":"1","article-title":"Guidelines for the Diagnosis and Treatment of Mild Cognitive Impairment in Parkinson\u2019s Disease in China (2020 Edition)","volume":"47","year":"2021","journal-title":"Chin J Nerv Ment Dis"},{"key":"2025121601434154000_14.11.e087164.36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.07.015","article-title":"Development and validation of an alternative version of the Parkinson\u2019s Disease-Cognitive Rating Scale (PD-CRS)","volume":"43","author":"Fern\u00e1ndez-Bobadilla","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"2025121601434154000_14.11.e087164.37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jocn.2011.11.039","article-title":"A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson\u2019s disease in China","volume":"19","author":"Nie","year":"2012","journal-title":"J Clin Neurosci"},{"key":"2025121601434154000_14.11.e087164.38","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22017"},{"key":"2025121601434154000_14.11.e087164.39","doi-asserted-by":"publisher","DOI":"10.1177\/0891988712445086"},{"key":"2025121601434154000_14.11.e087164.40","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/mds.23322","article-title":"Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson\u2019s disease","volume":"25","author":"Serrano-Due\u00f1as","year":"2010","journal-title":"Mov Disord"},{"key":"2025121601434154000_14.11.e087164.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.08.008"},{"key":"2025121601434154000_14.11.e087164.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.06.008"},{"key":"2025121601434154000_14.11.e087164.43","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429"},{"key":"2025121601434154000_14.11.e087164.44","article-title":"Risk of Bias 2 in Cochrane Reviews: a phased approach for the introduction of new methodology","volume":"10","author":"Flemyng","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121601434154000_14.11.e087164.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121601434154000_14.11.e087164.46","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.11.2.193"},{"key":"2025121601434154000_14.11.e087164.47","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"2025121601434154000_14.11.e087164.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-087164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:43:51Z","timestamp":1765878231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-087164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,20]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjopen-2024-087164"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-087164","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}